BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study.
De Alcubierre D, Gkasdaris G, Mordrel M, Joncour A, Briet C, Almairac F, Boetto J, Mouly C, Larrieu-Ciron D, Vasiljevic A, Villa C, Sergeant C, Ducray F, Feuvret L, Chanson P, Baussart B, Raverot G, Jouanneau E.
De Alcubierre D, et al. Among authors: sergeant c.
Eur J Endocrinol. 2024 Aug 5;191(2):251-261. doi: 10.1093/ejendo/lvae091.
Eur J Endocrinol. 2024.
PMID: 39158090